National University of Lesotho Pharmacy Students' Association - NULPSA

NUL’s Professor Maseabata Ramathebane Asses challenges and opportunities of treating breast cancer in Lesotho
________________________________
Brought to you by NUL Innovation Hub, Where Academia Meets Industry!

ABSTRACT

Background: It has been estimated that, more than 60% of the new breast cancer cases and 70% of related deaths will be seen in Low-Middle Income Countries in the coming 20 years. In Lesotho, out of 228 women, 177 had heard about breast cancer while 72.9% had heard of breast cancer screening. Given limited treatment facilities and options in Lesotho, many patients die soon after diagnosis, before they are able to access treatment; to date this cannot be quantified. Another challenge that affects breast cancer management is treatment and travel-related costs, particularly for those not living close to the medical centre. Most patients are coming with advanced disease stage and are sent home for home-based care, some of which could have been prevented with early screening.
Aim: The aim of study is to determine challenges faced by breast cancer patients, the cost to the health system and the opportunities this may bring to the country.
Methods: A quantitative cross-sectional, prospective and retrospective study was conducted on 45 breast cancer patients who were initiated chemotherapy at the only cancer treatment centre in Lesotho; Senkatana oncology clinic located at the Botshabelo complex in Maseru.
Results: The majority of patients were facing challenges of arranging transport to the doctor (83.3%, n=15), of being far from the healthcare facilities even if transportation was available (77.8%, n=14), paying for healthcare (83.3%, n=15), paying for transport (77.8%, n=14) and paying for diagnostic test (88.9%, n=16) in all ages. Majority of patients who presented for care and treatment late faced challenges more than those who presented earlier. Diagnostic and monitoring laboratory test constituted 64.5% of total direct medical costs followed by 24.7 % from chemotherapy.
Conclusion: The challenges faced by breast cancer patients are financial and practical nature and they get higher for patients who presented at advanced stage for care and treatment. In order to improve breast cancer care and treatment outcome at lower costs efforts for breast cancer awareness need to be intensified so that patients presented early at the health centers. In terms of direct medical cost, the largest cost came from the diagnostic and monitoring laboratory tests.
____________________________
Ramathebane, M., et al., (2023). Assessing challenges and opportunities of treating breast cancer in Lesotho. Medical Research Archives. https://doi.org/10.18103/mra.v11i11.4583

As future healthcare professionals, we recognize that pharmacy plays a vital role in building a healthier Africa through safe medication use, disease prevention, public health advocacy, research, and equitable healthcare access.
A stronger Africa begins with healthier communities, empowered healthcare systems, and united young leaders committed to excellence and service.
Happy African Union Day from the National University of Lesotho Pharmacy Students Association (NULPSA). 💊✨
“Promoting African unity through health, knowledge, and pharmaceutical care.”

Want to earn as you buy? Look no further. The revolutionary concept of Loyal Aid is here. Enjoy the exclusive discounts offered hussle free by joining the Loyal Aid Program. Visit your nearest Beautez Pharmacy to get your card and experience more value and more care.

Expert healthcare is now just a call away.
With Beautez Pharmacy Telemedicine Services, get professional medical advice, medication guidance, and quality care — anytime, anywhere. No queues. No long trips. Just convenient healthcare at your fingertips.
Beautez Pharmacy — bringing healthcare closer to you.

Healthcare should be accessible, professional, and trusted.

With Beautez Telemedicine, you can now consult qualified registered doctors anytime at Beautez Pharmacies — giving you faster access to expert healthcare, prescriptions, and medication support when you need it most.

Connect. Consult. Care.
Because your health deserves convenience without compromising quality.

Asthma is a chronic inflammatory condition where narrowed, hyperresponsive airways lead to wheezing, chest tightness, and breathlessness. Without proper control, it can silently worsen and trigger severe, life-threatening attacks.
Control goes beyond relief—consistent use of preventers like inhaled corticosteroids reduces airway inflammation, while correct inhaler technique ensures the medicine actually works.
At Beautez, you stay in control:
✔️ Inhaler technique support
✔️ Asthma counseling & medication reviews
✔️ Personalized trigger management advice
Don’t wait for an attack to act—breathe smarter, live better.

On the 10th May 2026, let's celebrate World Lupus Day, we confront one of the most complex autoimmune diseases—Systemic Lupus Erythematosus (SLE)—where immune tolerance collapses and the body turns its defense system against itself. At a molecular level, dysregulated B-cell activation drives the production of pathogenic autoantibodies (notably anti-dsDNA), forming immune complexes that deposit in tissues and trigger complement-mediated inflammation. The result is multi-organ damage—from lupus nephritis to neuropsychiatric involvement.
Pharmacological management is a delicate balance between immunosuppression and long-term safety. Cornerstones such as Hydroxychloroquine modulate antigen presentation and toll-like receptor signaling, reducing flares and improving survival. Corticosteroids like Prednisone provide rapid anti-inflammatory effects, while immunosuppressants including Mycophenolate mofetil and biologics such as Belimumab target specific immune pathways, reflecting a shift toward precision therapy.
Yet beyond pharmacology lies the human burden—fatigue, pain, and unpredictability. Awareness is not optional; it is therapeutic. Early diagnosis, adherence, and equitable access to advanced therapies can transform outcomes.
Shine a light. Advance the science. Support every warrior.
Beautez

Malaria is a life-threatening parasitic disease caused by Plasmodium species, transmitted through the bite of an infected female Anopheles mosquito. Once inside the body, parasites first infect the liver, multiply silently, and then enter the bloodstream where they invade red blood cells. Their repeated destruction of these cells leads to fever, chills, anemia, and fatigue.
In severe cases, especially with Plasmodium falciparum, infected red blood cells stick to blood vessel walls (cytoadherence), blocking microcirculation and causing organ damage—this is how complications like cerebral malaria, kidney failure, and acidosis develop.
From a physiological perspective, malaria disrupts oxygen delivery, triggers intense inflammatory responses, and can lead to metabolic disturbances such as hypoglycemia and lactic acidosis.
Treatment focuses on eliminating blood-stage parasites using artemisinin-based combination therapies (ACTs), while prevention relies on mosquito control, insecticide-treated nets, and eliminating stagnant water.
Malaria is preventable and treatable—but early action saves lives.